835 related articles for article (PubMed ID: 25216104)
1. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
Garton AB; Dudzinski J; Kowey PR
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
[TBL] [Abstract][Full Text] [Related]
2. [Periprocedural management of anticoagulation in patients undergoing atrial fibrillation ablation].
Park CI; Pruvot E; Jadidi A; Lehrmann H; Weber R; Arentz T; Zimmermann M
Rev Med Suisse; 2015 Mar; 11(464):557-60, 562. PubMed ID: 25924251
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
[TBL] [Abstract][Full Text] [Related]
6. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation.
Verma A; Tsang B
Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.
Briceño DF; Madan N; Romero J; Londoño A; Villablanca PA; Natale A; Di Biase L
Expert Opin Drug Saf; 2017 Jul; 16(7):769-777. PubMed ID: 28475380
[TBL] [Abstract][Full Text] [Related]
8. Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.
Gianni C; DI Biase L; Mohanty S; Trivedi C; Bai R; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton RP; Sanchez JE; Hranitzky PM; Lakkireddy D; Mansour MC; Santangeli P; Zado ES; Marchlinski FE; Beheiry S; Hao SC; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2016 Apr; 27(4):399-403. PubMed ID: 26756289
[TBL] [Abstract][Full Text] [Related]
9. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
10. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.
Blandino A; Bianchi F; Biondi-Zoccai G; Grossi S; Conte MR; Rametta F; Gaita F
J Interv Card Electrophysiol; 2016 Sep; 46(3):225-36. PubMed ID: 27217030
[TBL] [Abstract][Full Text] [Related]
11. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study.
Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP
J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
[TBL] [Abstract][Full Text] [Related]
14. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
[TBL] [Abstract][Full Text] [Related]
15. Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.
Zak M; Castiblanco SA; Garg J; Palaniswamy C; Jacobs LE
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):457-64. PubMed ID: 25827857
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
[TBL] [Abstract][Full Text] [Related]
17. Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.
Hayes CR; Keane D
J Interv Card Electrophysiol; 2010 Mar; 27(2):117-22. PubMed ID: 20082132
[TBL] [Abstract][Full Text] [Related]
18. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
[TBL] [Abstract][Full Text] [Related]
19. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
Michael Gray R; Nagendran M; Maruthappu M
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
[TBL] [Abstract][Full Text] [Related]
20. Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.
Dillier R; Ammar S; Hessling G; Kaess B; Pavaci H; Buiatti A; Semmler V; Kathan S; Hofmann M; Lennerz C; Kolb C; Reents T; Deisenhofer I
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):576-82. PubMed ID: 24970293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
